Science Explorer Back to mapMap
Discussion
Company · Liestal · Switzerland

Santhera Pharmaceuticals (Switzerland)

santhera.comROR OpenAlex
Research works
60
▼ 56% vs 2018-21
Citations
1.5k
24.6 per fractional work
Top-10% rate
14.2%
all institutions 10.0%
Open access
30%
world 40%
International
50%
world 18%
Santhera Pharmaceuticals (Switzerland)

Not ranked overall: Santhera Pharmaceuticals (Switzerland) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Santhera Pharmaceuticals (Switzerland) work in?

In all years, 55% of research at Santhera Pharmaceuticals (Switzerland) is in Life Sciences, 34% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (42%), Medicine (33%), Neuroscience (10%). It does 3.0× the world's share of Life Sciences.

Life Sciences: 33 fractional works · 54.5% of its workBiochemistry, Genetics and Molecular Biology: 25 fractional works · 41.8% of its workMolecular Biology: 22 fractional works · 35.9% of its workCell Biology: 3 fractional works · 4.8% of its workGenetics: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 6 fractional works · 9.9% of its workCellular and Molecular Neuroscience: 4 fractional works · 7.4% of its workEndocrine and Autonomic Systems: 1 fractional works · 1.4% of its workCognitive Neuroscience: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 1.5% of its workAnimal Science and Zoology: 1 fractional works · 1.0% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workToxicology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 0.6% of its workImmunology: 0 fractional works · 0.6% of its workHealth Sciences: 21 fractional works · 34.0% of its workMedicine: 20 fractional works · 32.6% of its workPhysiology: 4 fractional works · 6.2% of its workPulmonary and Respiratory Medicine: 3 fractional works · 4.6% of its workGenetics: 2 fractional works · 3.6% of its workOncology: 2 fractional works · 3.2% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 2.6% of its workComplementary and alternative medicine: 1 fractional works · 1.6% of its workGeriatrics and Gerontology: 1 fractional works · 1.4% of its workOphthalmology: 1 fractional works · 1.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.3% of its workEpidemiology: 1 fractional works · 1.1% of its workNeurology: 1 fractional works · 1.1% of its workSurgery: 0 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.7% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workRehabilitation: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.9% of its workNursing: 1 fractional works · 1.2% of its workNutrition and Dietetics: 1 fractional works · 1.2% of its workHealth Professions: 0 fractional works · 0.3% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 6.2% of its workChemistry: 2 fractional works · 3.7% of its workOrganic Chemistry: 2 fractional works · 3.4% of its workSpectroscopy: 0 fractional works · 0.4% of its workEngineering: 1 fractional works · 2.0% of its workBiomedical Engineering: 1 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workSocial Sciences: 3 fractional works · 5.2% of its workSocial Sciences: 1 fractional works · 1.6% of its workSociology and Political Science: 1 fractional works · 1.6% of its workPsychology: 1 fractional works · 1.6% of its workDevelopmental and Educational Psychology: 1 fractional works · 1.6% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.2% of its workEconomics and Econometrics: 1 fractional works · 1.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.8% of its workManagement Information Systems: 0 fractional works · 0.5% of its workStrategy and Management: 0 fractional works · 0.3% of its workALL ITS WORKSantheraPharmaceuticals…60fractional works, all years
Life Sciences55%Physical Sciences6%Health Sciences34%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2541.8%
    2. Neuroscience69.9%
    3. Agricultural and Biological Sciences11.5%
    4. Pharmacology, Toxicology and Pharmaceutics00.8%
    5. Immunology and Microbiology00.6%
    1. Medicine2032.6%
    2. Nursing11.2%
    3. Health Professions00.3%
    1. Chemistry23.7%
    2. Engineering12.0%
    3. Materials Science00.3%
    4. Physics and Astronomy00.2%
    1. Social Sciences11.6%
    2. Psychology11.6%
    3. Economics, Econometrics and Finance11.2%
    4. Business, Management and Accounting00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.85× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.47× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 7.02× its world share, 0 worksImmunology and Micro…Neuroscience: 3.91× its world share, 0 worksNeuroscienceChemistry: 1.18× its world share, 0 worksChemistryEngineering: 0.14× its world share, 0 worksEngineeringMaterials Science: 0.53× its world share, 0 worksMaterials ScienceMedicine: 2.78× its world share, 2 worksMedicinePsychology: 0.22× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.0×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Immunology and Microbiology7.02×0 works
  2. Neuroscience3.91×0 works
  3. Agricultural and Biological Sciences2.85×1 works
  4. Medicine2.78×2 works
  5. Biochemistry, Genetics and Molecular Biology2.47×1 works
  6. Chemistry1.18×0 works
  7. Materials Science0.53×0 works
  8. Psychology0.22×0 works
  9. Engineering0.14×0 works

Who are the top researchers at Santhera Pharmaceuticals (Switzerland)?

Ranked on the quality score, Mika Leinonen, Oliver Hill and I. Courdier-Fruh lead among researchers whose main affiliation is Santhera Pharmaceuticals (Switzerland).

  1. 1 Mika Leinonen Switzerland · #236,026 worldwide 6.2k citations · 60 works
  2. 2 Oliver Hill Switzerland · #2,565,882 worldwide 807 citations · 42 works
  3. 3 I. Courdier-Fruh Switzerland · #2,906,036 worldwide 1.1k citations · 21 works
  4. 4 Alexandre Briguet Switzerland · #3,029,433 worldwide 881 citations · 15 works
  5. 5 M. Leinonen Switzerland · #4,829,424 worldwide 743 citations · 49 works
All ranked researchers at Santhera Pharmaceuticals (Switzerland)

What are the most cited papers from Santhera Pharmaceuticals (Switzerland)?

The most cited paper from Santhera Pharmaceuticals (Switzerland) is "A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy" (Thomas Klopstock, Patrick Yu‐Wai‐Man, Konstantinos A. Dimitriadis et al., 2011), with 579 citations. Next come "Diagnosis and treatment of Friedreich ataxia: a European perspective" (263) and "A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia" (226).

Most cited papers
#PaperReleasedCitations
1 A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy Thomas Klopstock, Patrick Yu‐Wai‐Man, Konstantinos A. Dimitriadis et al. · Brain Open access 23 Jul 2011 579
2 Diagnosis and treatment of Friedreich ataxia: a European perspective Jörg Bernhard Schulz, Sylvia Boesch, Katrin Bürk et al. · Nature Reviews Neurology Review Apr 2009 263
3 A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia David R. Lynch, Susan Perlman, Thomas W. Meier · Archives of Neurology Open access Aug 2010 226
4 NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels Roman H. Haefeli, Michael A. Erb, Anja C. Gemperli et al. · PLoS ONE Open access 31 Mar 2011 188
5 Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial Gunnar Buyse, Thomas Voït, Ulrike Schara et al. · The Lancet Open access 20 Apr 2015 186
All 60 most cited papers, with filters and sorting

Which keywords describe research at Santhera Pharmaceuticals (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Stem Cells, Muscle Regeneration, Skeletal Muscle Atrophy, Mitochondrial Dysfunction, Mitochondria, Oxidative Stress, Metabolic Regulation and Aging.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Stem Cells11▲ 60×2 topics
  2. Muscle Regeneration11▲ 506×1 topic
  3. Skeletal Muscle Atrophy11▲ 506×1 topic
  4. Mitochondrial Dysfunction10▲ 46×6 topics
  5. Oxidative Stress8▲ 7.2×9 topics
  6. Mitochondria8▲ 77×3 topics
  7. Metabolic Regulation7▲ 41×4 topics
  8. Aging6▲ 20×6 topics
  9. Neurodegenerative Diseases6▲ 48×2 topics
  10. Reactive Oxygen Species6▲ 19×5 topics
  11. Cell Death5▲ 38×1 topic
  12. Mitochondrial Fusion5▲ 104×1 topic
  13. Cancer4▲ 4.5×5 topics
  14. Apoptosis3▲ 12×3 topics
  15. Neurodegeneration3▲ 15×4 topics
  16. Metabolism3▲ 6.8×5 topics
  17. Inhibitors3▲ 60×3 topics
  18. Cell Migration2▲ 49×3 topics
  19. Depression2▲ 5.4×4 topics
  20. Diabetes2▲ 7.7×2 topics
  21. Calpain2▲ 586×1 topic
  22. Exercise2▲ 26×2 topics
  23. Heart Failure2▲ 8.5×4 topics
  24. Proteolytic System2▲ 586×1 topic
  25. Cancer Therapy2▲ 5.8×7 topics
  26. Insulin Resistance2▲ 7.6×3 topics
  27. Antioxidant2▲ 4.9×4 topics
  28. Brown Adipose Tissue2▲ 46×1 topic
  29. Thermogenesis2▲ 46×1 topic
  30. SMN12▲ 130×1 topic
  31. Spinal Muscular Atrophy2▲ 130×1 topic
  32. Huntington's Disease2▲ 79×1 topic
  33. Protein Aggregation2▲ 35×1 topic
  34. Angiogenesis2▲ 6.5×2 topics
  35. Biosynthesis2▲ 18×1 topic
  36. Function2▲ 325×1 topic
  37. Type 2 Diabetes2▲ 13×2 topics
  38. Calcitonin Gene-Related Peptide1▲ 27×2 topics
  39. Cardiovascular Outcomes1▲ 56×1 topic
  40. Glucose Control1▲ 56×1 topic

Which research topics does Santhera Pharmaceuticals (Switzerland) publish most on?

By volume in 2022-now: Muscle Physiology and Disorders, Cystic Fibrosis Research Advances, Rabbits: Nutrition, Reproduction, Health and HER2/EGFR in Cancer Research.

Muscle Physiology and Disorders: 0 fractional worksCystic Fibrosis Research Advances: 0 fractional worksRabbits: Nutrition, Repr…0Rabbits: Nutrition, Reproduction, Health: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksHemophilia Treatment and Research: 0 fractional worksComplement system in diseases: 0 fractional worksCoccidia and coccidiosis research: 0 fractional worksAnimal Nutrition and Phy…0Animal Nutrition and Physiology: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional worksAlzheimer's disease research and treatments: 0 fractional works
Molecular BiologyPulmonary and Respiratory MedicineAnimal Science and ZoologyOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Muscle Physiology and Disorders Molecular Biology 0 works
  2. 2 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  3. 3 Rabbits: Nutrition, Reproduction, Health Animal Science and Zoology 0 works
  4. 4 HER2/EGFR in Cancer Research Oncology 0 works
  5. 5 Hemophilia Treatment and Research Hematology 0 works
  6. 6 Complement system in diseases Immunology 0 works
  7. 7 Coccidia and coccidiosis research Animal Science and Zoology 0 works
  8. 8 Animal Nutrition and Physiology Animal Science and Zoology 0 works
  9. 9 Cancer Treatment and Pharmacology Oncology 0 works
  10. 10 Alzheimer's disease research and treatments Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.5%not open69.5%

World: 40% of research is openly available.

with international co-authors50.3%domestic only49.7%

World: 18% is written across borders.

How has Santhera Pharmaceuticals (Switzerland)'s research output changed?

Output in 2022-2025 was 56% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Santhera Pharmaceuticals (Switzerland) as a percentage of every work published that year, 0.0000045% in 2024.

still counting0.00020%0.00040%0.00060%Santhera Pharmaceuticals (Switzerland)0.000034% in 202520102020

Fractional works of Santhera Pharmaceuticals (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Liestal

All research institutions in Liestal

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Santhera Pharmaceuticals (Switzerland). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.